STOCKHOLM, Dec. 19, 2019 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received CE Mark approval for its IRRAflow® catheter. This CE Mark complements the two CE Marks previously...
from PR Newswire: https://ift.tt/34yasUM
No comments:
Post a Comment